Cover Image

Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL

Aim: Targeted therapies have substantially improved the survival of patients with metastatic clear cell renal cell cancer. No prognostic or predictive biomarkers are available. Comprehensive genetic profiling offers the opportunity to define prognostic and predictive signatures aiming at a more pers...

Full description

Saved in:
Bibliographic Details
Main Authors: Dieffenbacher, Svenja (Author) , Zschäbitz, Stefanie (Author) , Hofer, Luisa (Author) , Hatiboglu, Gencay (Author) , Hou, Weibin (Author) , Hohenfellner, Markus (Author) , Duensing, Stefan (Author) , Sültmann, Holger (Author) , Pahernik, Sascha (Author) , Grüllich, Carsten (Author)
Format: Article (Journal)
Language:English
Published: 14 Mar 2018
In: Future Science OA
Year: 2018, Volume: 4, Issue: 5
ISSN:2056-5623
DOI:10.4155/fsoa-2017-0150
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.4155/fsoa-2017-0150
Verlag, kostenfrei, Volltext: https://www.future-science.com/doi/full/10.4155/fsoa-2017-0150
Get full text
Author Notes:Svenja Dieffenbacher, Stefanie Zschäbitz, Luisa Hofer, Gencay Hatiboglu, Weibin Hou, Markus Hohenfellner, Stefan Duensing, Holger Sültmann, Sascha Pahernik, Carsten Grüllich
Description
Summary:Aim: Targeted therapies have substantially improved the survival of patients with metastatic clear cell renal cell cancer. No prognostic or predictive biomarkers are available. Comprehensive genetic profiling offers the opportunity to define prognostic and predictive signatures aiming at a more personalized approach to treatment. Methods: In this prospectively conducted cohort study, tumor tissue and liquid biopsies are sampled at baseline and upon first and second progression under systemic treatment. Samples will be analyzed by whole-exome sequencing to generate prognostic and predictive patterns for systemic therapies. Discussion: This study is aiming at exploring genetic profiles with prognostic and predictive value in metastatic renal cell cancer patients. Clonal evolution facilitating resistance to systemic treatment will be investigated by repeat biopsies.
Item Description:Gesehen am 03.03.2020
Physical Description:Online Resource
ISSN:2056-5623
DOI:10.4155/fsoa-2017-0150

Similar Items